- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04886921
Women Underwent TRAM Surgery: Its Influence on Abdominal Muscle Function and the Effects of Therapeutic Exercises
Post-mastectomy Women Underwent Transverse Rectus Abdominis Musculocutaneous Flap (TRAM) Surgery: Its Influence on Abdominal Muscle Function and the Effects of Therapeutic Exercises
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Healthy adults
- Their age should be ranged between 30 - 60 years
TRAM flap surgery patients
- at least 6 months after the MS pedicled TRAM flap surgery
Exclusion Criteria:
Healthy adults
- a history of injury resulting in an inability to perform activities of daily living
- scoliosis or spinal surgery
- neurological, neuromuscular, rheumatological or systemic diseases
TRAM flap surgery patients
- tumor distant metastasis
- a history of injury resulting in an inability to perform activities of daily living
- scoliosis or spinal surgery
- neurological, neuromuscular, rheumatological or systemic diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TRAM abdominal muscle training group
Patients were recruited at least 6 months after the muscle-sparing (MS) pedicled Transverse rectus abdominis musculocutaneous (TRAM) flap procedure and at least 1 month after the conclusion of the last chemotherapy course, if any. All subjects will receive 1-hr training sessions consisting of core stability exercises for 12 weeks for the TRAM group. |
Participants will receive 12-week, 60 minutes, 36-session abdominal muscle training in the TRAM women.
Aimed to evaluate the effects on abdominal muscle functions after 12 weeks abdominal muscle training in the TRAM women.
Outcome measures were the clinical tests for trunk muscle strength, endurance and one-leg standing was also used to exam the abdominal muscle function.
|
No Intervention: TRAM control group
Patients were recruited at least 6 months after the muscle-sparing (MS) pedicled Transverse rectus abdominis musculocutaneous (TRAM) flap procedure and at least 1 month after the conclusion of the last chemotherapy course, if any. The control group was not received any exercise program. |
|
No Intervention: Healthy women group
A control group comprising female volunteers who were apparently healthy and had comparable socioeconomic backgrounds and physical conditions was recruited by convenience sampling from communities.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in thickness of abdominal wall muscles at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
|
Using the Ultrasound imaging to measure the thickness of all abdominal wall muscles at rest and in an isometric contraction.
|
The assessments will be conducted 1 and 12 weeks following the intervention
|
Changes in the cross-sectional area of the rectus abdominis muscle (RA) muscle at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
|
Using the Ultrasound imaging to measure the cross-sectional area of the rectus abdominis muscle at rest and in an isometric contraction.
|
The assessments will be conducted 1 and 12 weeks following the intervention
|
Changes in strength of the trunk muscles at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
|
Using the dynamometer and clinical tests (prone extension, curl-up and rotational curl-up) to measure the trunk strength
|
The assessments will be conducted 1 and 12 weeks following the intervention
|
Changes in endurance of the trunk muscles at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
|
Using the clinical tests (abdominal muscle test for strength, unsupported double bend leg lifting for static endurance) to measure the endurance of trunk muscles
|
The assessments will be conducted 1 and 12 weeks following the intervention
|
Changes in balanced functions at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
|
Using the seconds in the following static position to measure the balance: one-leg standing with the other lift-leg 1 inch of ground clearance; single leg standing with the other lift-leg hip flexion 90 degrees and the tibia vertical to the floor.
|
The assessments will be conducted 1 and 12 weeks following the intervention
|
Changes in muscle activity of selected trunk and limb muscles at 12-week
Time Frame: The assessments will be conducted 1 and 12 weeks following the intervention
|
Using A six-camera Qualisys motion system to measure the muscle activity of selected trunk and limb muscles.
|
The assessments will be conducted 1 and 12 weeks following the intervention
|
Collaborators and Investigators
Investigators
- Study Director: Li-Jiun Liaw, Kaohsiung Medical University Department of Physical Therapy Associate Professor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- KMUH-IRB-970469
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Neoplasms
-
Emory UniversityEisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Tumors, BreastUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
Providence Health & ServicesBrooklyn ImmunoTherapeutics, LLCActive, not recruitingBreast Neoplasm | Triple Negative Breast Cancer | Breast Neoplasm, MaleUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Dana-Farber Cancer InstituteConquer Cancer FoundationRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Spain, Israel, Canada, Belgium, United Kingdom, France, Tunisia
-
GlaxoSmithKlineCompletedNeoplasms, BreastUnited States, Canada, Germany, Spain, Taiwan, Belgium, Philippines, Israel, Hong Kong, Thailand, Pakistan, Russian Federation, Italy, Romania, China, France, Peru, United Kingdom, Czech Republic, Australia, Chile, Korea, Republic of and more
Clinical Trials on Abdominal muscle training
-
Norwegian School of Sport SciencesThe Norwegian Women´s Public Health AssociationCompletedDiastasis Recti | Diastasis Recti AbdominisNorway
-
Trakya UniversityCompletedStress Urinary Incontinence | Pelvic Floor Muscle Weakness
-
Liberate MedicalUnited States Department of DefenseEnrolling by invitationRespiration, Artificial | Ventilators, MechanicalUnited States, Australia
-
The University of Hong KongCompleted
-
National Taipei University of Nursing and Health...Cheng-Hsin General HospitalCompletedObstructive Sleep ApneaTaiwan
-
National Taipei University of Nursing and Health...Completed
-
National Taipei University of Nursing and Health...Completed
-
Istanbul Physical Medicine Rehabilitation Training...CompletedAdolescent Idiopathic Scoliosis | Muscle PhysiologyTurkey
-
Riphah International UniversityCompletedQuality of Life | Pelvic Floor Muscle Weakness | EndurancePakistan